The current status of erythromycin, kanamycin, novobiocin, oleandomycin, ristocetin, and vancomycin, with particular reference to their use in staphylococcal disease; panel discussion.
作者信息
FINLAND M, FOLTZ E, GERACI J E, KIRBY W M, QUINN E L, ROMANSKY M J, YOW E M
出版信息
Antibiot Annu. 1958;6:1051-72.
PMID:13637882
Abstract
摘要
Zotero 插件